Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mandy Ducy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Trends in Biochemical Sciences|January 15, 2019
The Tumor Suppressor PALB2: Inside OutMandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 23, 2019
Functional characterization of 84 PALB2 variants of uncertain significanceTimothy Wiltshire, Mandy Ducy, Tzeh Keong Foo, et al.
Nucleic Acids Research|October 6, 2019
A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressorAmélie Rodrigue, Guillaume Margaillan, Thiago Torres Gomes, et al.
EMBO Molecular Medicine|November 1, 2018
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutationMarta Castroviejo-Bermejo, Cristina Cruz, Alba Llop-Guevara, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Trends in Biochemical Sciences|January 15, 2019
The Tumor Suppressor PALB2: Inside OutMandy Ducy, Laura Sesma-Sanz, Laure Guitton-Sert, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 23, 2019
Functional characterization of 84 PALB2 variants of uncertain significanceTimothy Wiltshire, Mandy Ducy, Tzeh Keong Foo, et al.
Nucleic Acids Research|October 6, 2019
A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressorAmélie Rodrigue, Guillaume Margaillan, Thiago Torres Gomes, et al.
EMBO Molecular Medicine|November 1, 2018
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutationMarta Castroviejo-Bermejo, Cristina Cruz, Alba Llop-Guevara, et al.
Pageof 1